Alpha particle emitters have a high linear energy transfer and short range, offering the potential for treating micrometastases while sparing normal tissues. We developed a urea-based, (211)At-labeled small-molecule targeting prostate-specific membrane antigen (PSMA) for treatment of micrometastases due to prostate cancer (PC).
